Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Integrating Viral Vectors
1.2.3 Non-Integrating Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Metabolic Diseases
1.3.3 Cardiovascular Diseases
1.3.4 Muscular Diseases
1.3.5 Hematologic Diseases
1.3.6 Ophthalmologic Diseases
1.3.7 Infectious Diseases
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Gene Therapy Market Perspective (2018-2029)
2.2 Global Viral Gene Therapy Growth Trends by Region
2.2.1 Viral Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Viral Gene Therapy Historic Market Size by Region (2018-2024)
2.2.3 Viral Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Viral Gene Therapy Market Dynamics
2.3.1 Viral Gene Therapy Industry Trends
2.3.2 Viral Gene Therapy Market Drivers
2.3.3 Viral Gene Therapy Market Challenges
2.3.4 Viral Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Viral Gene Therapy by Players
3.1.1 Global Viral Gene Therapy Revenue by Players (2018-2024)
3.1.2 Global Viral Gene Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Viral Gene Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Viral Gene Therapy Market Concentration Ratio
3.4.1 Global Viral Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Gene Therapy Revenue in 2022
3.5 Global Key Players of Viral Gene Therapy Head office and Area Served
3.6 Global Key Players of Viral Gene Therapy, Product and Application
3.7 Global Key Players of Viral Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Gene Therapy Breakdown Data by Type
4.1 Global Viral Gene Therapy Historic Market Size by Type (2018-2024)
4.2 Global Viral Gene Therapy Forecasted Market Size by Type (2024-2029)
5 Viral Gene Therapy Breakdown Data by Application
5.1 Global Viral Gene Therapy Historic Market Size by Application (2018-2024)
5.2 Global Viral Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Viral Gene Therapy Market Size (2018-2029)
6.2 North America Viral Gene Therapy Market Size by Type
6.2.1 North America Viral Gene Therapy Market Size by Type (2018-2024)
6.2.2 North America Viral Gene Therapy Market Size by Type (2024-2029)
6.2.3 North America Viral Gene Therapy Market Share by Type (2018-2029)
6.3 North America Viral Gene Therapy Market Size by Application
6.3.1 North America Viral Gene Therapy Market Size by Application (2018-2024)
6.3.2 North America Viral Gene Therapy Market Size by Application (2024-2029)
6.3.3 North America Viral Gene Therapy Market Share by Application (2018-2029)
6.4 North America Viral Gene Therapy Market Size by Country
6.4.1 North America Viral Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Viral Gene Therapy Market Size by Country (2018-2024)
6.4.3 North America Viral Gene Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Viral Gene Therapy Market Size (2018-2029)
7.2 Europe Viral Gene Therapy Market Size by Type
7.2.1 Europe Viral Gene Therapy Market Size by Type (2018-2024)
7.2.2 Europe Viral Gene Therapy Market Size by Type (2024-2029)
7.2.3 Europe Viral Gene Therapy Market Share by Type (2018-2029)
7.3 Europe Viral Gene Therapy Market Size by Application
7.3.1 Europe Viral Gene Therapy Market Size by Application (2018-2024)
7.3.2 Europe Viral Gene Therapy Market Size by Application (2024-2029)
7.3.3 Europe Viral Gene Therapy Market Share by Application (2018-2029)
7.4 Europe Viral Gene Therapy Market Size by Country
7.4.1 Europe Viral Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Viral Gene Therapy Market Size by Country (2018-2024)
7.4.3 Europe Viral Gene Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Viral Gene Therapy Market Size (2018-2029)
8.2 China Viral Gene Therapy Market Size by Type
8.2.1 China Viral Gene Therapy Market Size by Type (2018-2024)
8.2.2 China Viral Gene Therapy Market Size by Type (2024-2029)
8.2.3 China Viral Gene Therapy Market Share by Type (2018-2029)
8.3 China Viral Gene Therapy Market Size by Application
8.3.1 China Viral Gene Therapy Market Size by Application (2018-2024)
8.3.2 China Viral Gene Therapy Market Size by Application (2024-2029)
8.3.3 China Viral Gene Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Viral Gene Therapy Market Size (2018-2029)
9.2 Asia Viral Gene Therapy Market Size by Type
9.2.1 Asia Viral Gene Therapy Market Size by Type (2018-2024)
9.2.2 Asia Viral Gene Therapy Market Size by Type (2024-2029)
9.2.3 Asia Viral Gene Therapy Market Share by Type (2018-2029)
9.3 Asia Viral Gene Therapy Market Size by Application
9.3.1 Asia Viral Gene Therapy Market Size by Application (2018-2024)
9.3.2 Asia Viral Gene Therapy Market Size by Application (2024-2029)
9.3.3 Asia Viral Gene Therapy Market Share by Application (2018-2029)
9.4 Asia Viral Gene Therapy Market Size by Region
9.4.1 Asia Viral Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Viral Gene Therapy Market Size by Region (2018-2024)
9.4.3 Asia Viral Gene Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Viral Gene Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Viral Gene Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Viral Gene Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Viral Gene Therapy Introduction
11.1.4 Lonza Revenue in Viral Gene Therapy Business (2018-2024)
11.1.5 Lonza Recent Developments
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Viral Gene Therapy Introduction
11.2.4 Biogen Revenue in Viral Gene Therapy Business (2018-2024)
11.2.5 Biogen Recent Developments
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Viral Gene Therapy Introduction
11.3.4 Catalent Revenue in Viral Gene Therapy Business (2018-2024)
11.3.5 Catalent Recent Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Viral Gene Therapy Introduction
11.4.4 Gilead Sciences Revenue in Viral Gene Therapy Business (2018-2024)
11.4.5 Gilead Sciences Recent Developments
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Details
11.5.2 Sarepta Therapeutics Business Overview
11.5.3 Sarepta Therapeutics Viral Gene Therapy Introduction
11.5.4 Sarepta Therapeutics Revenue in Viral Gene Therapy Business (2018-2024)
11.5.5 Sarepta Therapeutics Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Viral Gene Therapy Introduction
11.6.4 Novartis Revenue in Viral Gene Therapy Business (2018-2024)
11.6.5 Novartis Recent Developments
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Viral Gene Therapy Introduction
11.7.4 Amgen Revenue in Viral Gene Therapy Business (2018-2024)
11.7.5 Amgen Recent Developments
11.8 Ionis Pharmaceuticals
11.8.1 Ionis Pharmaceuticals Company Details
11.8.2 Ionis Pharmaceuticals Business Overview
11.8.3 Ionis Pharmaceuticals Viral Gene Therapy Introduction
11.8.4 Ionis Pharmaceuticals Revenue in Viral Gene Therapy Business (2018-2024)
11.8.5 Ionis Pharmaceuticals Recent Developments
11.9 Spark Therapeutics
11.9.1 Spark Therapeutics Company Details
11.9.2 Spark Therapeutics Business Overview
11.9.3 Spark Therapeutics Viral Gene Therapy Introduction
11.9.4 Spark Therapeutics Revenue in Viral Gene Therapy Business (2018-2024)
11.9.5 Spark Therapeutics Recent Developments
11.10 Shanghai Sunway Biotech
11.10.1 Shanghai Sunway Biotech Company Details
11.10.2 Shanghai Sunway Biotech Business Overview
11.10.3 Shanghai Sunway Biotech Viral Gene Therapy Introduction
11.10.4 Shanghai Sunway Biotech Revenue in Viral Gene Therapy Business (2018-2024)
11.10.5 Shanghai Sunway Biotech Recent Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Viral Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Viral Gene Therapy Business (2018-2024)
11.11.5 SIBIONO Recent Developments
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Viral Gene Therapy Introduction
11.12.4 AnGes Revenue in Viral Gene Therapy Business (2018-2024)
11.12.5 AnGes Recent Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Viral Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Viral Gene Therapy Business (2018-2024)
11.13.5 Orchard Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Viral Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Integrating Viral Vectors
Table 3. Key Players of Non-Integrating Viral Vectors
Table 4. Global Viral Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Viral Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Viral Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Viral Gene Therapy Market Share by Region (2018-2024)
Table 8. Global Viral Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Viral Gene Therapy Market Share by Region (2024-2029)
Table 10. Viral Gene Therapy Market Trends
Table 11. Viral Gene Therapy Market Drivers
Table 12. Viral Gene Therapy Market Challenges
Table 13. Viral Gene Therapy Market Restraints
Table 14. Global Viral Gene Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Viral Gene Therapy Revenue Share by Players (2018-2024)
Table 16. Global Top Viral Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2022)
Table 17. Global Viral Gene Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Viral Gene Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Viral Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Viral Gene Therapy, Product and Application
Table 21. Global Key Players of Viral Gene Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Viral Gene Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Viral Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Viral Gene Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Viral Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Viral Gene Therapy Revenue Share by Application (2018-2024)
Table 29. Global Viral Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Viral Gene Therapy Revenue Share by Application (2024-2029)
Table 31. North America Viral Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Viral Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Viral Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Viral Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Viral Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Viral Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Viral Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Viral Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Viral Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Viral Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Viral Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Viral Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Viral Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Viral Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Viral Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Viral Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Viral Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Viral Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Viral Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Viral Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Viral Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Viral Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 63. Lonza Company Details
Table 64. Lonza Business Overview
Table 65. Lonza Viral Gene Therapy Product
Table 66. Lonza Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 67. Lonza Recent Developments
Table 68. Biogen Company Details
Table 69. Biogen Business Overview
Table 70. Biogen Viral Gene Therapy Product
Table 71. Biogen Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 72. Biogen Recent Developments
Table 73. Catalent Company Details
Table 74. Catalent Business Overview
Table 75. Catalent Viral Gene Therapy Product
Table 76. Catalent Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 77. Catalent Recent Developments
Table 78. Gilead Sciences Company Details
Table 79. Gilead Sciences Business Overview
Table 80. Gilead Sciences Viral Gene Therapy Product
Table 81. Gilead Sciences Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 82. Gilead Sciences Recent Developments
Table 83. Sarepta Therapeutics Company Details
Table 84. Sarepta Therapeutics Business Overview
Table 85. Sarepta Therapeutics Viral Gene Therapy Product
Table 86. Sarepta Therapeutics Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 87. Sarepta Therapeutics Recent Developments
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Viral Gene Therapy Product
Table 91. Novartis Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 92. Novartis Recent Developments
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Viral Gene Therapy Product
Table 96. Amgen Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 97. Amgen Recent Developments
Table 98. Ionis Pharmaceuticals Company Details
Table 99. Ionis Pharmaceuticals Business Overview
Table 100. Ionis Pharmaceuticals Viral Gene Therapy Product
Table 101. Ionis Pharmaceuticals Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 102. Ionis Pharmaceuticals Recent Developments
Table 103. Spark Therapeutics Company Details
Table 104. Spark Therapeutics Business Overview
Table 105. Spark Therapeutics Viral Gene Therapy Product
Table 106. Spark Therapeutics Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 107. Spark Therapeutics Recent Developments
Table 108. Shanghai Sunway Biotech Company Details
Table 109. Shanghai Sunway Biotech Business Overview
Table 110. Shanghai Sunway Biotech Viral Gene Therapy Product
Table 111. Shanghai Sunway Biotech Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 112. Shanghai Sunway Biotech Recent Developments
Table 113. SIBIONO Company Details
Table 114. SIBIONO Business Overview
Table 115. SIBIONO Viral Gene Therapy Product
Table 116. SIBIONO Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 117. SIBIONO Recent Developments
Table 118. AnGes Company Details
Table 119. AnGes Business Overview
Table 120. AnGes Viral Gene Therapy Product
Table 121. AnGes Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 122. AnGes Recent Developments
Table 123. Orchard Therapeutics Company Details
Table 124. Orchard Therapeutics Business Overview
Table 125. Orchard Therapeutics Viral Gene Therapy Product
Table 126. Orchard Therapeutics Revenue in Viral Gene Therapy Business (2018-2024) & (US$ Million)
Table 127. Orchard Therapeutics Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Viral Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Integrating Viral Vectors Features
Figure 4. Non-Integrating Viral Vectors Features
Figure 5. Global Viral Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Viral Gene Therapy Market Share by Application: 2022 VS 2029
Figure 7. Metabolic Diseases Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Muscular Diseases Case Studies
Figure 10. Hematologic Diseases Case Studies
Figure 11. Ophthalmologic Diseases Case Studies
Figure 12. Infectious Diseases Case Studies
Figure 13. Others Case Studies
Figure 14. Viral Gene Therapy Report Years Considered
Figure 15. Global Viral Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Viral Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Viral Gene Therapy Market Share by Region: 2022 VS 2029
Figure 18. Global Viral Gene Therapy Market Share by Players in 2022
Figure 19. Global Top Viral Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Viral Gene Therapy Revenue in 2022
Figure 21. North America Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Viral Gene Therapy Market Share by Type (2018-2029)
Figure 23. North America Viral Gene Therapy Market Share by Application (2018-2029)
Figure 24. North America Viral Gene Therapy Market Share by Country (2018-2029)
Figure 25. United States Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Viral Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Viral Gene Therapy Market Share by Type (2018-2029)
Figure 29. Europe Viral Gene Therapy Market Share by Application (2018-2029)
Figure 30. Europe Viral Gene Therapy Market Share by Country (2018-2029)
Figure 31. Germany Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Viral Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Viral Gene Therapy Market Share by Type (2018-2029)
Figure 39. China Viral Gene Therapy Market Share by Application (2018-2029)
Figure 40. Asia Viral Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Viral Gene Therapy Market Share by Type (2018-2029)
Figure 42. Asia Viral Gene Therapy Market Share by Application (2018-2029)
Figure 43. Asia Viral Gene Therapy Market Share by Region (2018-2029)
Figure 44. Japan Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Viral Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Viral Gene Therapy Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Viral Gene Therapy Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Viral Gene Therapy Market Share by Country (2018-2029)
Figure 54. Brazil Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Viral Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Lonza Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 61. Biogen Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 62. Catalent Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 63. Gilead Sciences Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 64. Sarepta Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 65. Novartis Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 66. Amgen Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 67. Ionis Pharmaceuticals Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 68. Spark Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 69. Shanghai Sunway Biotech Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 70. SIBIONO Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 71. AnGes Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 72. Orchard Therapeutics Revenue Growth Rate in Viral Gene Therapy Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed